Charles Schwab Investment Management »

Aerovate Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Aerovate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aerovate Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aerovate Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $61k 29k 2.09
2024-06-30 $87k 52k 1.66
2024-03-31 $915k 31k 29.57
2023-12-31 $669k 30k 22.63
2023-09-30 $401k 30k 13.57
2023-06-30 $457k 27k 17.15
2023-03-31 $497k 25k 20.17
2022-12-31 $722k 25k 29.30
2022-09-30 $394k 24k 16.59
2022-06-30 $373k 24k 15.65
2022-03-31 $603k 33k 18.35
2021-12-31 $292k 25k 11.80
2021-09-30 $519k 25k 20.98